AbbVie strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million expansion of its Singapore manufacturing facility.
AbbVie strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 million expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie’s global network. Located in…